v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
Total revenue
Operating expenses:    
Research and development, net of reimbursements 4,201 7,700
General and administrative 1,702 8,938
Total operating expenses 5,903 16,638
Loss from operations (5,903) (16,638)
Other income:    
Interest income - net 381 700
Total other income 381 700
Net loss $ (5,522) $ (15,938)
Net loss per share of common stock – basic (in Dollars per share) $ (0.18) $ (0.51)
Net loss per share of common stock – diluted (in Dollars per share) $ (0.18) $ (0.51)
Weighted average common shares outstanding – basic (in Shares) 31,237,681 31,195,891
Weighted average common shares outstanding – diluted (in Shares) 31,237,681 31,195,891
Revenue    
Revenue:    
Total revenue
Other Revenue    
Revenue:    
Total revenue